Protein-protein and protein-chromatin interactions of LEDGF/p75 as novel drug targets
- PMID: 29233296
- DOI: 10.1016/j.ddtec.2017.11.002
Protein-protein and protein-chromatin interactions of LEDGF/p75 as novel drug targets
Abstract
Lens epithelium-derived growth factor p75 (LEDGF/p75), a transcriptional co-activator, plays an important role in tethering protein complexes to the chromatin. Through this tethering function LEDGF/p75 is implicated in a diverse set of human diseases including HIV infection and mixed lineage leukemia, an aggressive form of cancer with poor prognosis. Here we provide an overview of recent progress in resolving protein-protein and protein-chromatin interaction mechanisms of LEDGF/p75. This review will focus on two well-characterized domains, the PWWP domain and the integrase binding domain (IBD). The PWWP domain interacts with methylated lysine 36 in histone H3, a marker of actively transcribed genes. The IBD interacts with the IBD binding motif, available in cellular binding partners of LEDGF/p75. Each domain forms an interesting new target for drug discovery.
Copyright © 2017. Published by Elsevier Ltd.
Similar articles
-
Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.J Mol Biol. 2006 Jul 21;360(4):760-73. doi: 10.1016/j.jmb.2006.04.073. Epub 2006 May 17. J Mol Biol. 2006. PMID: 16793062
-
HIV-1 integrase modulates the interaction of the HIV-1 cellular cofactor LEDGF/p75 with chromatin.Retrovirology. 2011 Apr 21;8:27. doi: 10.1186/1742-4690-8-27. Retrovirology. 2011. PMID: 21510906 Free PMC article.
-
The Structure-Specific Recognition Protein 1 Associates with Lens Epithelium-Derived Growth Factor Proteins and Modulates HIV-1 Replication.J Mol Biol. 2016 Jul 17;428(14):2814-31. doi: 10.1016/j.jmb.2016.05.013. Epub 2016 May 21. J Mol Biol. 2016. PMID: 27216501 Free PMC article.
-
The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.Virology. 2013 Jan 5;435(1):102-9. doi: 10.1016/j.virol.2012.09.033. Virology. 2013. PMID: 23217620 Review.
-
[LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].Yao Xue Xue Bao. 2009 Sep;44(9):953-60. Yao Xue Xue Bao. 2009. PMID: 20055168 Review. Chinese.
Cited by
-
The Emerging Roles of the Stress Epigenetic Reader LEDGF/p75 in Cancer Biology and Therapy Resistance: Mechanisms and Targeting Opportunities.Cancers (Basel). 2024 Nov 26;16(23):3957. doi: 10.3390/cancers16233957. Cancers (Basel). 2024. PMID: 39682146 Free PMC article. Review.
-
Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance.Int J Mol Sci. 2023 Apr 12;24(8):7130. doi: 10.3390/ijms24087130. Int J Mol Sci. 2023. PMID: 37108293 Free PMC article.
-
Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase.Future Sci OA. 2018 Sep 6;4(9):FSO338. doi: 10.4155/fsoa-2018-0060. eCollection 2018 Oct. Future Sci OA. 2018. PMID: 30416746 Free PMC article. Review.
-
Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions.Front Cell Dev Biol. 2019 May 15;7:81. doi: 10.3389/fcell.2019.00081. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31157223 Free PMC article. Review.
-
Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.Cells. 2023 Aug 11;12(16):2046. doi: 10.3390/cells12162046. Cells. 2023. PMID: 37626856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials